Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Packaging
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Analysis

ProBioGen AG

www.probiogen.de

Goethestrasse 54
Berlin
13086
Germany

+49 30 924 006-0

Activities

Manufacturing | Research & Development | Pharmaceutical

Related Companies

  • Envair Technology
  • Curia
  • Titan Enterprises
  • Piramal Pharma Solutions
  • PCI Pharma Services
  • Owen Mumford
  • Beamex
  • Lonza
  • Merck KGaA
  • Upperton Pharma Solutions
  • Austar
  • PSL Powder Systems
  • Vetter Pharma International
  • Labtex
  • Huber
  • Cytiva
  • Hermes Pharma GmbH
  • GEA Pharma and Healthcare
  • Silverson Machines
  • Burkert Fluid Control Systems

Related Content

AstraZeneca licenses GlymaxX tech for drug discovery
AstraZeneca licenses GlymaxX tech for drug discovery
Innovent licenses ProBioGen’s GlymaxX technology
Innovent licenses ProBioGen’s GlymaxX technology
ProBioGen platform reaches Phase III clinical development
ProBioGen platform reaches Phase III clinical development
ProBioGen gets green light for cell line tech research license
ProBioGen gets green light for cell line tech research license
Nobelpharma licenses ProBioGen’s AGE1.CR.pIX vaccine platform
Nobelpharma licenses ProBioGen’s AGE1.CR.pIX vaccine platform
ValenzaBio licences ProBioGen’s GlymaxX technology
ValenzaBio licences ProBioGen’s GlymaxX technology
ProBioGen and Heat Biologics enter research licence agreement
ProBioGen and Heat Biologics enter research licence agreement
ProBioGen and LAVA Therapeutics sign cell line agreement
ProBioGen and LAVA Therapeutics sign cell line agreement
ProBioGen and Minapharm incorporate subsidiary
ProBioGen and Minapharm incorporate subsidiary
Asher contracts ProBioGen to develop lead candidate
Asher contracts ProBioGen to develop lead candidate
Nouscom licenses ProBioGen’s vaccine production cell line
Nouscom licenses ProBioGen’s vaccine production cell line
ProBioGen to assist manufacturing on Nobelpharma vaccine project
ProBioGen to assist manufacturing on Nobelpharma vaccine project
ProBioGen signs multi-product license agreement with Sanofi
ProBioGen signs multi-product license agreement with Sanofi
Developing novel antibody therapeutics
Developing novel antibody therapeutics
ProBioGen and Eucodis agree to commercialise a novel antibody drug conjugation technology
ProBioGen and Eucodis agree to commercialise a novel antibody drug conjugation technology
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company